Cormorant Asset Management, LP's Form 4 filing
BioAge Labs, Inc. (BIOA) · filed Oct 1, 2024
- Accession no.
- 0000929638-24-003363
- Filed
- Oct 1, 2024, 4:01 PM ET
- Trade date
- Sep 27, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market purchases total $8.10M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cormorant Asset Management, LPCIK 0001583977 | Other: Former 10% Owner |
| Chen BihuaCIK 0001599214 | Other: Former 10% Owner |
| Cormorant Private Healthcare Fund IV LPCIK 0001871297 | Other: Former 10% Owner |
| Cormorant Private Healthcare Fund V LPCIK 0001969296 | Other: Former 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 27, 2024 | Common Stock | CConversionAcquired | +1,179,529 | – | – | 1,179,529 | Indirect | |
| Sep 27, 2024 | Common Stock | PPurchaseAcquired | +450,000 | $18.00 | +$8,100,000 | 1,629,529 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 27, 2024 | Common Stock | CConversionDisposed | −1,179,529 | – | – | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.